Corrigendum to "P-REX1 amplification promotes progression of cutaneous melanomavia the PAK1/P38/MMP-2 pathway" [Cancer Lett. 407 (2017) 66-75].

Publication Title

Cancer letters

Authors

Jinhua Wang
Hajime Hirose, Department of Translational Medicine, Division Molecular Oncology, John Wayne Cancer Institute (JWCI) at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA.
Guanhua Du
Kelly Chong, Department of Translational Medicine, Division Molecular Oncology, John Wayne Cancer Institute (JWCI) at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA.Follow
Eiji Kiyohara, Department of Translational Medicine, Division Molecular Oncology, John Wayne Cancer Institute (JWCI) at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA.
Isaac P Witz
Dave S B Hoon, Department of Translational Medicine, Division Molecular Oncology, John Wayne Cancer Institute (JWCI) at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA.Follow

Document Type

Article

Publication Date

7-28-2024

Keywords

california; sjci

Clinical Institute

Cancer

Specialty

Oncology

DOI

10.1016/j.canlet.2024.216966

Recommended Citation

Wang, Jinhua; Hirose, Hajime; Du, Guanhua; Chong, Kelly; Kiyohara, Eiji; Witz, Isaac P; and Hoon, Dave S B, "Corrigendum to "P-REX1 amplification promotes progression of cutaneous melanomavia the PAK1/P38/MMP-2 pathway" [Cancer Lett. 407 (2017) 66-75]." (2024). Articles, Abstracts, and Reports. 8824.
https://digitalcommons.providence.org/publications/8824
10.1016/j.canlet.2024.216966